Inogen is the manufacturer of the Inogen One and an Accredited Homecare provider, meaning you get the best of both worlds – quality product from the product experts and first rate customer service with the ability to bill Medicare/Insurance.
Inogen is a Nationwide Accredited Homecare provider that specializes in oxygen therapy
Inogen has an A+ rating with the Better Business Bureau
Inogen is proud to manufacture the Inogen One in the USA
Inogen maintains the highest quality standards and is certified to ISO13485
Inogen was awarded the Frost & Sullivan Oxygen Therapy Product of the Year for the Inogen One
The Inogen One G2 received a Gold award in the Medical Design Excellence Awards competition
Inogen was awarded the Design of the Decade for the Inogen One
*This video contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements concerning or implying Inogen’s future growth prospects. Forward-looking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from currently anticipated results, including but not limited to, risks arising from the possibility that Inogen will not realize anticipated growth; the impact of reduced reimbursement rates, including in connection with the implementation of the competitive bidding and the newly released Center for Medicare and Medicaid Services (CMS) rules; the possibility that Inogen’s business growth will not be sufficient to support headcount expansion; and challenges related to improving asset utilization. In addition, Inogen’s business is subject to numerous additional risks and uncertainties, including risks related to the recently filed securities litigation pending against Inogen in United States District Court for the Central District of California. Information on certain of these risks, uncertainties, and other information affecting Inogen’s business and operating results are contained in Inogen’s Annual Report on Form 10-K for the year ended December 31, 2014 and in Inogen’s subsequent reports on Form 10-Q and Form 8-K. These forward-looking statements speak only as of 6/12/15. Inogen disclaims any obligation to update these forward-looking statements except as may be required by law.
